Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 7
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Estimation de la probabilité de transmission du VIH chez les donneurs hommes ayant des relations sexuelles avec d’autres hommes à l’aide de modèles biocomportementaux et mathématiques | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Estimation de la probabilité de transmission du VIH chez les donneurs hommes ayant des relations sexuelles avec d’autres hommes à l’aide de modèles biocomportementaux et mathématiques | General public | MSM research |
Salvianolic acid B inhibits thrombosis and directly blocks the thrombin catalytic site | Neves MAD, Ni TT, Mackeigan DT, Shoara AA, Lei X, Slavkovic S, Yu SY, Stratton TW, Gallant RC, Zhang D, Xu XR, Fernandes C, Zhu G, Hu X, Chazot N, Donaldson LW, Johnson PE, Connelly K, Rand M, Wang Y, Ni H | 2024 | Res Pract Thromb Haemost | View Salvianolic acid B inhibits thrombosis and directly blocks the thrombin catalytic site | Researchers | Basic research |
Lay Science Writing Competition 2024: Understanding graft versus host disease (GvHD) | Rosenflanz K | 2024 | Research.Education.Discovery (R.E.D.) Blog | View Lay Science Writing Competition 2024: Understanding graft versus host disease (GvHD) | General public | Other |
Antagonism of the Platelet-Activating Factor Pathway Mitigates Inflammatory Adverse Events Driven by Anti-erythrocyte Antibody Therapy in Mice | Won KD, Gil Gonzalez L, Cruz-Leal Y, Pavon Oro A, Lazarus AH | 2024 | J Immunol | View Antagonism of the Platelet-Activating Factor Pathway Mitigates Inflammatory Adverse Events Driven by Anti-erythrocyte Antibody Therapy in Mice | Researchers | Basic research |
FAQ : fin du Programme de dons dirigés de la Société canadienne du sang | Ning S | 2024 | Blood.ca website | View FAQ : fin du Programme de dons dirigés de la Société canadienne du sang | Health care providers | Benchmarking and standard setting |
Améliorer la sécurité du traitement par IgIV pour les patients | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Améliorer la sécurité du traitement par IgIV pour les patients | General public | Other |
CBR External Travel Awards: Norman Bethune Symposium 2024 – Fateme Babaha | Babaha F | 2024 | Centre for Blood Research Blog | View CBR External Travel Awards: Norman Bethune Symposium 2024 – Fateme Babaha | General public | Other |
Traitements par immunoglobulines intraveineuses : comprendre leur fonctionnement | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Impact de la recherche | View Traitements par immunoglobulines intraveineuses : comprendre leur fonctionnement | General public | Other |
Ferroptosis in liver diseases: Fundamental mechanism and clinical implications | Lai MS, Yan XP, Branch DR, Loriamini M, Chen LM | 2024 | World J Gastroenterol | View Ferroptosis in liver diseases: Fundamental mechanism and clinical implications | Health care providers | Clinical research |
SARS-CoV-2 vaccination in Canadian blood donors: Insight into donor representativeness of the general population | O'Brien SF, Goldman M, Ehsani-Moghaddam B, Fan W, Osmond L, Pambrun C, Drews SJ | 2024 | Vaccine X | View SARS-CoV-2 vaccination in Canadian blood donors: Insight into donor representativeness of the general population | Researchers | Epidemiology research |
Factor V haemostatic diathesis impairing thrombin activation, membrane binding and circulating antigen level due to a novel compound heterozygous mutation, Leu1821Ser and Gly2192Cys | Talbot K, Song J, Perrier JR, Jackson S, MacGillivray RTA, Pryzdial ELG | 2024 | Haemophilia | View Factor V haemostatic diathesis impairing thrombin activation, membrane binding and circulating antigen level due to a novel compound heterozygous mutation, Leu1821Ser and Gly2192Cys | Researchers | Basic research |
RBC subpopulations in RCCs affected by donor factors | Yazdanbakhsh M, Phan C, William N, Acker JP | 2024 | Transfus Apher Sci | View RBC subpopulations in RCCs affected by donor factors | Researchers | Benchmarking and standard setting |
Comparative genome analyses of Staphylococcus aureus from platelet concentrates reveal rearrangements involving loss of type VII secretion genes | Ramirez-Arcos S, Ighem-Chi S, Flint A, Weedmark K, Pagotto F | 2024 | Access Microbiol | View Comparative genome analyses of Staphylococcus aureus from platelet concentrates reveal rearrangements involving loss of type VII secretion genes | Researchers | Basic research |
Introduire un nouveau produit sanguin pour mieux répondre aux besoins transfusionnels des Forces armées canadiennes | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Introduire un nouveau produit sanguin pour mieux répondre aux besoins transfusionnels des Forces armées canadiennes | General public | Other |
Prehospital Freeze-Dried Plasma in Trauma: A Critical Review | Sheffield WP, Singh K, Beckett A, Devine DV | 2024 | Transfus Med Rev | View Prehospital Freeze-Dried Plasma in Trauma: A Critical Review | Researchers | Benchmarking and standard setting |
International review of blood donation nucleic acid amplification testing | Faddy HM, Osiowy C, Custer B, Busch M, Stramer SL, Adesina O, van de Laar T, Tsoi W-C, Styles C, Kiely P, Margaritis A, Kwon S-Y, Qiu Y, Deng X, Lewin A, Jørgensen SW, Erikstrup C, Juhl D, Sauleda S, Camacho Rodriguez BA, Coral LJCS, Gaviria García PA, Oota S, O'Brien SF, Wendel S, Castro E, Navarro Pérez L, Harvala H, Davison K, Reynolds C, Jarvis L, Grabarczyk P, Kopacz A, Łętowska M, O'Flaherty N, Young F, Williams P, Burke L, Chua SS, Muylaert A, Page I, Jones A, Niederhauser C, Vermeulen M, Laperche S, Gallian P, Sawadogo S, Satake M, Gharehbaghian A, Addas-Carvalho M, Blanco S, Gallego SV, Seltsam A, Weber-Schehl M, Al-Riyami AZ, Al Maamari K, Alawi FB, Pandey HC, Mbanya D, França RA, Charlewood R, the Virology Surveillance Risk Assessment Policy subgroups of the ISBT Working Party on Transfusion-transmitted Infectious Diseases | 2024 | Vox Sang | View International review of blood donation nucleic acid amplification testing | Blood operators | Benchmarking and standard setting |
Improving blood safety through a risk-informed approach to complex decision-making | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Improving blood safety through a risk-informed approach to complex decision-making | General public | Other |
Antagonism of the Platelet-Activating Factor Pathway Mitigates Inflammatory Adverse Events Driven by Anti-erythrocyte Antibody Therapy in Mice | Won KD, Gil Gonzalez L, Cruz-Leal Y, Pavon Oro A, Lazarus AH | 2024 | J Immunol | View Antagonism of the Platelet-Activating Factor Pathway Mitigates Inflammatory Adverse Events Driven by Anti-erythrocyte Antibody Therapy in Mice | Researchers | Basic research |
Operational impact of individual risk assessment options | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Operational impact of individual risk assessment options | General public | MSM research |
Intravenous immunoglobulin therapies: Understanding how and why they work | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Research Impact Case Study | View Intravenous immunoglobulin therapies: Understanding how and why they work | General public | Other |
Countdown to CSTM 2024: Bringing research to life | Haw J | 2024 | Research.Education.Discovery (R.E.D.) Blog | View Countdown to CSTM 2024: Bringing research to life | General public | Other |
Current state of undergraduate medical school training in transfusion medicine and its impact on postgraduate trainee knowledge | Rahmani M, Chargé S, Bodnar M, Callum J, Hsia C, Lavoie M, Lemay AS, Mack J, Prokopchuk-Gauk O, Trudeau J, Zeller MP, Lin Y | 2024 | Transfusion | View Current state of undergraduate medical school training in transfusion medicine and its impact on postgraduate trainee knowledge | Health care providers | Education research |
Cultured CD71+ erythroid cells modulate the host immune response | Alshalani A, Beuger BM, van Bruggen R, Acker JP, Juffermans NP | 2023 | Transfus Med | View Cultured CD71+ erythroid cells modulate the host immune response | Researchers | Basic research |
Importance du fer chez les donneurs de sang total : la perspective canadienne | Khandelwal A, Pambrun C, Goldman M | 2023 | Blood.ca website | View Importance du fer chez les donneurs de sang total : la perspective canadienne | Health care providers | Benchmarking and standard setting |
The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety | Parmar G, Allan DS, Morris G, Dibdin N, Ganz K, Mostert K, Paulson K, Petraszko T, Stevens N, Seftel MD | 2023 | Curr Oncol | View The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety | Health care providers | Clinical research |
Engineered Compounds to Control Ice Nucleation and Recrystallization | William N, Mangan S, Ben RN, Acker JP | 2023 | Ann Rev Biomed Eng | View Engineered Compounds to Control Ice Nucleation and Recrystallization | Researchers | New or improved product or process |
The under-appreciated world of the serpin family of serine proteinase inhibitors | Bouton M-C, Geiger M, Sheffield WP, Irving JA, Lomas DA, Song S, Satyanarayanan RS, Zhang L, McFadden G, Lucas AR | 2023 | EMBO Mol Med | View The under-appreciated world of the serpin family of serine proteinase inhibitors | Researchers | Basic research |
Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021 | Lin Y-CJ, Evans DH, Robbins NF, Orjuela G, Abe KT, Rathod B, Colwill K, Gingras A-C, Tuite A, Yi Q-L, O’Brien SF, Drews SJ | 2023 | Microbiol Spectr | View Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021 | Researchers | Clinical research |
Risk of variant Creutzfeldt–Jakob disease in a simulated cohort of Canadian blood donors | Pozzo di Borgo A, Germain M, O'Brien SF, Delage G, Renaud C, Lewin A | 2023 | Vox Sang | View Risk of variant Creutzfeldt–Jakob disease in a simulated cohort of Canadian blood donors | Researchers | Clinical research |
Comparison of three dosing intervals for the primary vaccination of the SARS-CoV-2 mRNA Vaccine (BNT162b2) on magnitude, neutralization capacity and durability of the humoral immune response in health care workers: A prospective cohort study | Leong DP, Zhang A, Breznik JA, Clare R, Huynh A, Mushtaha M, Rangarajan S, Stacey H, Kim PY, Loeb M, Denburg JA, Mertz D, Chagla Z, Nazy I, Miller MS, Bowdish DME, Duong M | 2023 | PLoS One | View Comparison of three dosing intervals for the primary vaccination of the SARS-CoV-2 mRNA Vaccine (BNT162b2) on magnitude, neutralization capacity and durability of the humoral immune response in health care workers: A prospective cohort study | Researchers | Clinical research |
FAQ : Information destinée aux professionnels de la santé qui commandent des concentrés de granulocytes | Stepien J, Robert M-H | 2023 | Blood.ca website | View FAQ : Information destinée aux professionnels de la santé qui commandent des concentrés de granulocytes | Health care providers | Benchmarking and standard setting |
SARS-CoV-2 cross-sectional seroprevalence study among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, Canada | Watts AW, Mâsse LC, Goldfarb DM, Irvine MA, Hutchison SM, Muttucomaroe L, Poon B, Barakauskas VE, O’Reilly C, Bosman E, Reicherz F, Coombs D, Pitblado M, O’Brien SF, Lavoie PM | 2023 | BMJ Open | View SARS-CoV-2 cross-sectional seroprevalence study among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, Canada | Researchers | Clinical research |
The Specialist in Transfusion Science program | Clarke G, Holovati J | 2023 | Immunohematology | View The Specialist in Transfusion Science program | Researchers | Benchmarking and standard setting |
Plan de mejora para el proceso de inventarios de la empresa Zoomania clinica Veterinaria S.A.S | Ramirez-Arcos S | 2023 | Tecnológico de Antioquia | View Plan de mejora para el proceso de inventarios de la empresa Zoomania clinica Veterinaria S.A.S | Researchers | Basic research |
Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness | Shaver N, Katz M, Darko Asamoah G, Linkins L-A, Abdelkader W, Beck A, Bennett A, Hughes SE, Smith M, Begin M, Coyle D, Piggott T, Kagina BM, Welch V, Colijn C, Earn DJD, El Emam K, Heffernan J, O'Brien SF, Wilson K, Collins E, Navarro T, Beyene J, Boutron I, Bowdish D, Cooper C, Costa A, Curran J, Griffith L, Hsu A, Grimshaw J, Langlois M-A, Li X, Pham-Huy A, Raina P, Rubini M, Thabane L, Wang H, Xu L, Brouwers M, Horsley T, Lavis J, Iorio A, Little J | 2023 | Vaccine | View Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness | Researchers | Benchmarking and standard setting |
Do Children With an Allergic Transfusion Reaction Require Premedication or All Blood Products? | Bahabri A, Barty R, Li N, Liu Y, Kovalova T, Chan AKC | 2023 | J Pediatr Hematol Oncol | View Do Children With an Allergic Transfusion Reaction Require Premedication or All Blood Products? | Health care providers | Clinical research |
How do we forecast tomorrow's transfusion? Applying social science approaches to meet tomorrow's transfusion needs: Blood donors and donation | Haw J, Holloway K, Goldman M | 2023 | Transfus Clin Biol | View How do we forecast tomorrow's transfusion? Applying social science approaches to meet tomorrow's transfusion needs: Blood donors and donation | Researchers | Ethical, legal & social implications research |
Antigen copy number and antibody dose can determine the outcome of erythrocyte alloimmunization inducing either antibody-mediated immune suppression or enhancement in a murine model | Wabnitz H, Cruz-Leal Y, Lazarus AH | 2023 | Transfusion | View Antigen copy number and antibody dose can determine the outcome of erythrocyte alloimmunization inducing either antibody-mediated immune suppression or enhancement in a murine model | Researchers | Basic research |
La maladie hémolytique du nouveau-né (incompatibilité ABO) | International Collaboration for Transfusion Medicine Guidelines | 2023 | ICTMG.org | View La maladie hémolytique du nouveau-né (incompatibilité ABO) | General public | Other |
Desialylated Platelet Clearance in the Liver is a Novel Mechanism of Systemic Immunosuppression | Li J, Karakas D, Xue F, Chen Y, Zhu G, Yucel YH, MacParland SA, Zhang H, Semple JW, Freedman J, Shi Q, Ni H | 2023 | Research | View Desialylated Platelet Clearance in the Liver is a Novel Mechanism of Systemic Immunosuppression | Researchers | Basic research |
Transfusion Camp Rwanda: A prospective feasibility study evaluating the delivery of Transfusion Camp to a multidisciplinary group of postgraduate medical trainees in Rwanda | Hagumimana J, Skelton T, Pendergrast J, Nizeyimana F, Masaisa F, Kanyamuhunga A, Gashaija C, Chargé S, Kapitany C, Morgan M, Meirovich H, Lin Y | 2023 | Transfusion | View Transfusion Camp Rwanda: A prospective feasibility study evaluating the delivery of Transfusion Camp to a multidisciplinary group of postgraduate medical trainees in Rwanda | Health care providers | Education research |
Prevalence and significance of large granular lymphocytes in patients with immune thrombocytopenia | Gabe C, Liu Y, Duncan J, St John M, Lucier KJ, Kimmel D, Kelton JG, Arnold DM | 2023 | Platelets | View Prevalence and significance of large granular lymphocytes in patients with immune thrombocytopenia | Researchers | Clinical research |
An expanded role for blood donor emerging pathogens surveillance | O’Brien SF, Goldman M, Drews S | 2023 | CMAJ | View An expanded role for blood donor emerging pathogens surveillance | Blood operators | New or improved product or process |
Transmission of Variant Creutzfeldt-Jakob Disease Through Blood Transfusion and Plasma-Derived Products: A Narrative Review of Observed and Modeled Risks | Pozzo di Borgo A, Rochette S, Gaussen A, O'Brien SF, Germain M, Renaud C, Lewin A | 2023 | Transfus Med Rev | View Transmission of Variant Creutzfeldt-Jakob Disease Through Blood Transfusion and Plasma-Derived Products: A Narrative Review of Observed and Modeled Risks | Researchers | Benchmarking and standard setting |
Taking lessons from nature to improve cell therapy cryopreservation | Acker J, William N, Coatham M | 2023 | Cell Gene Ther Insights | View Taking lessons from nature to improve cell therapy cryopreservation | Researchers | Basic research |
Molecular Screening of Blood Donors for Babesia in Tyrol, Austria | Bloch EM, Siller A, Tonnetti L, Drews SJ, Spencer BR, Hedges D, Mergenthal T, Weber-Schehl M, Astl M, Patel EU, Gaber M, Schennach H | 2023 | Transfus Med Hemother | View Molecular Screening of Blood Donors for Babesia in Tyrol, Austria | Researchers | Clinical research |
Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S | Huynh A, Arnold DM, Michael JV, Clare R, Smith JW, Daka M, Ianosi-Irimie M, McKenzie SE, Kelton JG, Nazy I | 2023 | Blood Adv | View Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S | Researchers | Clinical research |
Donor sex, pre-donation hemoglobin, and manufacturing affect CD71+ cells in red cell concentrates | Li W, William N, Acker JP | 2023 | Transfusion | View Donor sex, pre-donation hemoglobin, and manufacturing affect CD71+ cells in red cell concentrates | Researchers | Basic research |
The high prevalence of occult hepatitis B infections among the partners of chronically infected HBV blood donors emphasizes the potential residual risk to blood safety | Ye X, Li T, Yu B, Zeng J, Shi Y, Xie H, Branch DR, Loriamini M, Li B, Chen L | 2023 | J Med Virol | View The high prevalence of occult hepatitis B infections among the partners of chronically infected HBV blood donors emphasizes the potential residual risk to blood safety | Blood operators | Clinical research |
HIV Pre-Exposure Prophylaxis, Blood Donor Deferral, Occult Infection, and Risk of HIV Transmission by Transfusion: A Fine Balance Between Evidence-Based Donor Selection Criteria and Transfusion Safety | Leblanc J-F, Custer B, Van de Laar T, Drews SJ, Germain M, Lewin A | 2023 | Transfus Med Rev | View HIV Pre-Exposure Prophylaxis, Blood Donor Deferral, Occult Infection, and Risk of HIV Transmission by Transfusion: A Fine Balance Between Evidence-Based Donor Selection Criteria and Transfusion Safety | Researchers | Clinical research |